ArticleACR open rheumatology2025

Soluble Co-Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case-Control Study.

Elvis Hysa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.